China NMPA Product Recall - defibrillator

Philips (China) Investment Co., Ltd. initiated a voluntary Class II recall for specific defibrillator models, including HeartStart MRx, HeartStart XL, and HeartStart XL+, as reported to the National Medical Products Administration (NMPA) and published on December 12, 2014. The recall stems from a reported issue where, under AC power and when connected to an auxiliary bedside monitor via a synchronization cable, the defibrillators may experience interference from electrical fast transient bursts (EFT). This interference can lead to critical malfunctions: on HeartStart MRx and HeartStart XL devices, EFT noise may be incorrectly interpreted as R-waves. For HeartStart XL+ units, EFT noise could disable ECG monitoring and interrupt on-demand pacing. While an existing instruction manual warning for the XL+ addresses a contributing factor, Philips is proactively addressing the broader risk. In response, Philips Medical Systems is implementing corrective actions by replacing the affected synchronization cables free of charge. Philips representatives are contacting users of the implicated devices to coordinate the cable replacement process, ensuring patient safety and device reliability in clinical settings.